Clinical Potential of Anti-inflammatory Effects of Faecalibacterium Prausnitzii and Butyrate in Inflammatory Bowel Disease

Inflamm Bowel Dis. 2019 Mar 14;25(4):e40-e41. doi: 10.1093/ibd/izy258.

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Inflammatory Agents
  • Butyrates
  • Colitis*
  • Colorectal Neoplasms*
  • Faecalibacterium prausnitzii
  • Histone Deacetylase 1
  • Humans
  • Inflammatory Bowel Diseases*
  • T-Lymphocytes, Regulatory

Substances

  • Anti-Inflammatory Agents
  • Butyrates
  • Histone Deacetylase 1